Midgard Science

Quotient Sciences

Garnet Valley, PA, United States quotientsciences.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Quotient Sciences provides integrated contract research, development, and manufacturing services for small molecule and synthetic peptide drug programs. It supports pharma and biotech clients across early clinical development, drug product development and manufacturing, and commercial supply from facilities in the US and UK.

Services

  • Drug Product Development & Manufacturing

    Formulation development and drug product manufacturing services from preclinical stages through commercial supply.

  • Early Clinical Development

    First-in-human and clinical pharmacology programs, including Phase I and Phase I/IIa studies.

  • Translational Pharmaceutics® Integrated Drug Development

    An integrated approach combining formulation development, drug product manufacturing, and clinical testing in one program.

  • Clinical Pharmacology Studies

    Exploratory and regulatory-driven Phase 1 clinical pharmacology studies such as DDI, human ADME, BA/BE, food effect, and TQT.

  • Human ADME Studies

    Integrated human mass balance and 14C radiolabeled ADME studies for regulatory filings.

  • Pharmacy Compounding

    Integrated pharmacy compounding and GMP manufacturing to support first-in-human clinical testing and later proof-of-concept trials.

  • Commercial Drug Product Manufacturing

    Commercial manufacturing and sustained supply for solid oral dosage forms, including niche and small-volume products.

    CDMO: development & manufacturing

  • Scale-Up & CDMO Tech-Transfer

    Technology transfer and scale-up support from lab or pilot scale into registration batches and commercial supply.

8 more services
  • High Potency API Handling & Drug Product Manufacturing
  • Pediatric Formulation Development
  • Drug Substance Synthesis & Manufacturing
  • Preclinical Technology Screening
  • Clinical Trial Manufacturing
  • Commercial Manufacturing
  • Global Clinical Trial Supplies
  • AI-Enhanced Formulation Development
Turnaround
Less than seven days
What to send
  • 14C drug products tailored to specific program requirements
  • IV products where appropriate for human ADME studies
Minimums and prices
$8-30 million savings in runway costs by reaching proof-of-concept sooner

Capabilities

Assays and studies
  • Small molecules
  • Peptides
  • Single ascending dose (SAD)
  • Multiple ascending dose (MAD)
  • Drug-drug interaction (DDI)
  • Human ADME
13 more
  • Bioavailability/bioequivalence (BA/BE)
  • Food effect
  • Thorough QT (TQT)
  • Bioanalysis
  • Pharmacokinetics
  • Statistics
  • Clinical programming
  • Pharmacodynamic studies
  • Biomarker studies
  • Pharmacokinetic studies
  • Taste assessment
  • Tablet dissolution
  • In vitro drug release
Scale and capacity
  • More than 1,300 Phase I studies delivered
  • Database of 31,500+ active healthy volunteers
  • Two Philadelphia sites approved for Phase I–III clinical manufacturing and commercial drug product manufacturing
  • Third site in the planning stages
  • Batch sizes from less than 1 kg to over 400 kg
  • Up to 500 kg for solid oral dosage forms in commercial drug product
  • 2,500 ft² compounding pharmacy
  • Less than seven days for manufacture and release of drug products
Therapeutic areas
  • Inflammation
  • Metabolic diseases
  • CNS disorders
  • Oncology
  • Rare diseases
  • GI/gastroenterology
10 more
  • Cardiovascular
  • Dermatology
  • Endocrinology
  • GI
  • Haematology
  • Immunology
  • Hepatology
  • Infectious disease
  • Nephrology
  • Pediatrics

Instruments and platforms

  • Translational Pharmaceutics®
  • Synthesis-to-Clinic®
  • USP 795/797/800 clean room
  • Proprietary AI algorithm
  • Digital twin

Modalities and species

Modalities
  • Small molecule
  • Peptide
Species and models
  • Healthy volunteers
  • Special populations
  • Patient cohorts
  • Healthy smokers
  • Healthy elderly
  • High BMI
4 more
  • Post-menopausal women
  • Japanese
  • Chinese
  • Healthy participants

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: drug product manufacturing

Details

Type
CRDMO
Founded
1990
Based in
Garnet Valley, PA, United States
Sites
  • Miami, United States
  • Nottingham, United Kingdom
  • Philadelphia, United States
  • Boothwyn, United States
  • Philadelphia, PA, United States
Serves
US, UK, global

Public records

Parent company
QUOTIENT SCIENCES LIMITED · GB GLEIF
Biocom California CRO directory
drug development, Drug Product Manufacturing, drug substance API manufacturing, Formulation Development, small molecule source
FDA drug establishment registration
3003882011 · ANALYSIS; MANUFACTURE source
CMS CLIA laboratory
10D1098266 · MIAMI source

Similar labs